stay despit disappoint guidanc
remain overweight-r share despit disappoint guidanc
believ despit known pressur point busi manag track
record conservativ respect initi guidanc deliv result deserv
benefit doubt hardli expect aimovig impress launch make
loss legaci eros pipelin progress wildcard bold-strok
 deal enough keep attent
solid top/bottom-lin beat post ww product revenu beat
consensu pjc driven strong perform aimovig
sensipar neulasta though note us biosimilar competit neulasta wasnt
sever expect quarter though opex higher consensu
non-gaap ep nice beat consensu pjc
oy guidanc big off-set howev disappoint guidanc
revenu guidanc well consensu
non-gaap ep guidanc also consensu
cite broad-bas competit pressur across portfolio sensipar enbrel
aranesp neulasta clear amgn legaci franchis face competit howev
work shown pressur time think manag
team deserv benefit doubt term commerci execut
compani histori conserv initi guidanc would surpris
rais guidanc even today environ least year
deal deal time sound like pull trigger
bolt-on deal understand rare reward investor
acquir least initi trust manag team disciplin process
lower pt adjust revenu estim primarili sensipar
neulasta within guid rang revenu previous
ep previous chang valuat
methodolog price target decreas lower ep
estim appli multipl ep discount back
bottom line despit guidanc disappoint continu recommend
global biopharmaceut compani
price close januari
ep discount back
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
page
good sold
product sale
total revenu
sell gener administr
total revenu
statement oper
dollar except per share data
provis incom tax tax benefit
current disclosur inform compani locat http //www piperjaffray com/researchdisclosur
current disclosur inform compani locat http //www piperjaffray com/researchdisclosur
page
dollar except per share data
total aimovig revenu
current disclosur inform compani locat http //www piperjaffray com/researchdisclosur
